Outlining the Key Considerations for Developing Potency Assays for Arenavirus-Based Gene Therapy Products Meet Regulatory Demands

Time: 4:00 pm
day: Day 2


  • Outlining the emergence of gene therapy modalities beyond traditional AAV approaches
  • Evaluation of appropriate potency assays to reflect the Mode of action of arenaviral therapeutics
  • Why T cells matter – challenges in the development of CD8+ T cell activation assays